
United-Guardian's cosmetic ingredient growth supports higher Q2 sales and earnings per share, while other income also strengthens the results.
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products in the United States and internationally. The company is headquartered in Hauppauge, New York.
| Revenue (TTM) | $11.21M |
| Gross Profit (TTM) | $5.26M |
| EBITDA | $2.45M |
| Operating Margin | 24.30% |
| Return on Equity | 21.30% |
| Return on Assets | 10.80% |
| Revenue/Share (TTM) | $2.44 |
| Book Value | $2.44 |
| Price-to-Book | 2.82 |
| Price-to-Sales (TTM) | 2.93 |
| EV/Revenue | 2.075 |
| EV/EBITDA | 9.49 |
| Quarterly Earnings Growth (YoY) | 16.20% |
| Quarterly Revenue Growth (YoY) | 9.50% |
| Shares Outstanding | $4.59M |
| Float | $2.96M |
| % Insiders | 35.85% |
| % Institutions | 20.36% |
Volatility is currently contracting

United-Guardian's cosmetic ingredient growth supports higher Q2 sales and earnings per share, while other income also strengthens the results.

HAUPPAUGE, N.Y., Aug. 07, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the second quarter and first half of 2026. Second quarter net sales increased by 10% from $2,838,225 in 2025 to $3,108,267 in 2026, with net income increasing 16% from $626,826 ($0.14 per share) to $728,579 ($0.16 per share). Net sales for the six-month period ended June 30th increased by 12% from $5,319,352 in 2025 to $5,980,489 in 2026, and net income increased by 30% from $1,187,721 ($0.26 per share) to $1,547,481 ($0.34 per share).

HAUPPAUGE, N.Y., July 16, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today that the company's Board of Directors, at its meeting on July 14, 2026, declared a cash dividend of $0.30 per share, to be paid on August 4, 2026, to all stockholders of record as of the close of business on July 28, 2026.

United-Guardian's rally reflects stronger sales, distribution expansion and recovering cosmetic demand, but valuation and trade risks may limit its near-term appeal.

UG reports higher y/y earnings and sales in Q1, driven by strong demand for Renacidin and increased purchases of cosmetic ingredients.

United-Guardian, Inc. (UG) Shareholder/Analyst Call Transcript

HAUPPAUGE, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the first quarter of 2026. First quarter sales increased from $2,481,127 in 2025 to $2,872,222 in 2026, with net income increasing from $560,895 ($0.12 per share) to $818,902 ($0.18 per share).
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on UG and any ticker you trade — then tracks every position and per-strategy win rate.